OM

Opaleye Management Portfolio holdings

AUM $494M
1-Year Est. Return 68.17%
This Quarter Est. Return
1 Year Est. Return
+68.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$350M
AUM Growth
+$37.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
48
New
Increased
Reduced
Closed

Top Buys

1
+$7.31M
2
+$7.23M
3
+$3.95M
4
PTCT icon
PTC Therapeutics
PTCT
+$3.92M
5
TGTX icon
TG Therapeutics
TGTX
+$3.89M

Top Sells

1
+$18M
2
+$14.5M
3
+$12.4M
4
AXGN icon
Axogen
AXGN
+$9.31M
5
CRSP icon
CRISPR Therapeutics
CRSP
+$6.6M

Sector Composition

1 Healthcare 93.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$62.6M 17.9%
1,715,000
-255,000
2
$55M 15.73%
600,000
-135,000
3
$20.7M 5.92%
179,400
+3,100
4
$18.7M 5.35%
1,700,600
5
$16.6M 4.76%
14,400
6
$14.1M 4.02%
1,590,000
+340,000
7
$12.2M 3.49%
1,065,000
+5,000
8
$10.6M 3.04%
130,000
9
$10.6M 3.02%
873,000
+26,100
10
$10.2M 2.91%
535,000
-45,000
11
$8.64M 2.47%
665,000
12
$7.31M 2.09%
+365,000
13
$7.23M 2.07%
+1,111,000
14
$6.48M 1.85%
320,200
15
$5.73M 1.64%
1,135,600
+235,600
16
$5.71M 1.63%
190,000
-20,000
17
$5.25M 1.5%
87,250
+44,250
18
$4.91M 1.4%
90,000
-330,000
19
$4.87M 1.39%
950,000
-10,000
20
$4.81M 1.38%
1,100,800
+620,242
21
$4.08M 1.17%
80,000
-10,000
22
$4.06M 1.16%
1,095,100
+655,100
23
$3.95M 1.13%
+150,000
24
$3.92M 1.12%
+145,000
25
$3.89M 1.11%
+274,200
1
2